z-logo
open-access-imgOpen Access
Development of Autoimmune Hypothyroidism after Interferon-beta 1a Treatment in Patient with Multiple Sclerosis: A Case Report
Author(s) -
Abdul Awal,
Sunny Anam Chowdhury,
Hafizur Rahman
Publication year - 2018
Publication title -
bangladesh journal of nuclear medicine
Language(s) - English
Resource type - Journals
ISSN - 1562-3831
DOI - 10.3329/bjnm.v19i2.36014
Subject(s) - multiple sclerosis , medicine , interferon beta , autoimmune disease , interferon , demyelinating disease , immunology , central nervous system , disease
Interferon beta therapy is a well-established treatment of patients suffering from multiple sclerosis, a demyelinating disease of the central nervous system. Since type I interferons have immunomodulatory properties, these cytokines may trigger several autoimmune disorders. In this case, we report the development of autoimmune hypothyroidism in a multiple sclerosis patients receiving interferon-β 1a. Bangladesh J. Nuclear Med. 19(2): 149-151, July 2016

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here